[Mental disorders and neuropeptides].
Moroji
T
T
Department of Psychopharmacology, Psychiatric Research Institute of Tokyo.
Katsuura
G
G
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001921:Brain / Q000378:metabolism; D002766:Cholecystokinin / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology; D003866:Depressive Disorder / Q000378:metabolism*; D004723:Endorphins / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D009479:Neuropeptides / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D018377:Neurotransmitter Agents; D012559:Schizophrenia / Q000378:metabolism*
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D004723:Endorphins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D002766:Cholecystokinin